Cantor Fitzgerald, L. P. Silence Therapeutics PLC Transaction History

Cantor Fitzgerald, L. P.

$8.4 Billion
Q3 2025

A detailed history of Cantor Fitzgerald, L. P. transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 801,306 shares of SLN stock, worth $5.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

801,306

Previous 801,306 -0.0%

Holding current value

$5.5 Million

Previous $4.16 Million -0.0%

% of portfolio

0.05%

Previous 0.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$4.51 - $6.49 $55,324 - $79,612	12,267 Added 1.55%	801,306 $4.16 Million
Q2 2025 Aug 14, 2025	BUY	$2.18 - $6.09 $33,122 - $92,531	15,194 Added 1.96%	789,039 $4.58 Million
Q1 2025 May 15, 2025	BUY	$2.82 - $7.41 $660,215 - $1.73 Million	234,119 Added 43.38%	773,845 $2.18 Million
Q4 2024 Feb 14, 2025	BUY	$6.33 - $19.65 $1.3 Million - $4.04 Million	205,534 Added 61.5%	539,726 $3.71 Million
Q3 2024 Nov 14, 2024	BUY	$15.53 - $21.74 $1.34 Million - $1.87 Million	86,226 Added 34.77%	334,192 $6.08 Million

Q2 2024 Aug 14, 2024	BUY	$18.31 - $23.91 $2.65 Million - $3.45 Million	144,483 Added 139.62%	247,966 $4.71 Million
Q1 2024 May 15, 2024	SELL	$17.39 - $26.25 $752,882 - $1.14 Million	-43,294 Reduced 29.5%	103,483 $2.24 Million
Q4 2023 Feb 14, 2024	SELL	$6.7 - $17.67 $985,677 - $2.6 Million	-147,116 Reduced 50.06%	146,777 $2.55 Million
Q2 2023 Aug 14, 2023	BUY	$4.61 - $7.44 $21,828 - $35,228	4,735 Added 1.64%	293,893 $1.62 Million
Q1 2023 May 15, 2023	SELL	$6.2 - $15.61 $77,698 - $195,624	-12,532 Reduced 4.15%	289,158 $1.79 Million
Q4 2022 Feb 14, 2023	BUY	$9.69 - $17.09 $889,580 - $1.57 Million	91,804 Added 43.74%	301,690 $4.6 Million
Q3 2022 Nov 14, 2022	SELL	$2.65 - $29.85 $4,171 - $46,983	-1,574 Reduced 0.74%	209,886 $2.11 Million
Q2 2022 Aug 15, 2022	BUY	$7.99 - $19.5 $301,502 - $735,832	37,735 Added 21.72%	211,460 $2.51 Million
Q1 2022 May 16, 2022	SELL	$16.5 - $23.89 $1.33 Million - $1.93 Million	-80,794 Reduced 31.74%	173,725 $3.3 Million
Q4 2021 Feb 14, 2022	BUY	$20.61 - $25.71 $5.25 Million - $6.54 Million	254,519 New	254,519 $6.08 Million

Others Institutions Holding SLN

# of Institutions

Shares Held

20.6M

Call Options Held

Put Options Held

View Full List

About Silence Therapeutics plc

Ticker SLN
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,888,400
Market Cap $247M
Description
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...

More about SLN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

News

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.

Account

Cantor Fitzgerald, L. P. Silence Therapeutics PLC Transaction History